ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2922

Outcomes of Lupus Nephritis in Vulnerable Populations

Christine Peschken1, Rebecca Gole2, Carol A Hitchon3, David Robinson3, Ada Man4, Annaliese Tisseverasinghe4 and Hani El-Gabalawy4, 1Medicine & Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, 2University of Manitoba, Winnipeg, MB, Canada, 3Arthritis Center, University of Manitoba, Winnipeg, MB, Canada, 4Rheumatology, University of Manitoba, Winnipeg, MB, Canada

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Ethnic studies, health disparities, lupus nephritis and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 8, 2017

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment V: Longterm Outcomes

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose:

Lupus nephritis is a known predictor of mortality; we have previously shown an increased frequency of nephritis in North American Indian (NAI) and Asian (ASN) lupus patients. We examined the risks of end-stage renal disease (ESRD) and death among lupus nephritis patients, and included the impact of ethnicity, low income (LowInc), lack of education (LowEduc), and living >500 km from rheumatology care (Remote).

Methods:

Patients from a single academic center were followed from 1990-2016 using a custom database. Records of all SLE patients were abstracted. Variables included birthdate, diagnosis date, ethnicity, ACR classification criteria (ACRc), SLICC Damage Index (SDI) including ESRD, treatment and date of death. Ethnicity was categorized into NAI, Caucasian (CAU), ASN and Other. In patients who had developed nephritis, Kaplan Meier and Cox proportional hazard models were used to compare ESRD and survival between vulnerable groups.

Results:

Nine hundred forty-four SLE patients were identified: 240 (25%) NAI, 576(60%) CAU, 104(11%) ASN and 24(2.5%) Other. “Other” patients were excluded. Mean disease duration was 14 years, 89% female. Nephritis developed in 39% of CAU (n= 224), 57% of NAI (n=136; OR 2.1; 95%CI 1.5-2.8), and 75% of ASN (n=76; OR 4.7; 95%CI 2.9-7.6), p<0.001. Twenty percent of patients had not completed high school, 20% were LowInc, and 11% were Remote; LowInc, LowEduc, and Remote did not increase the odds of nephritis. Among nephritis patients, ESRD developed in 11%, and 17% died. Comparing nephritis patients (N=436), NAI (29±15) and ASN (29±13) years were younger at diagnosis; CAU (36±16), p<0.001. Disease duration was similar in NAI and ASN, both (11years±13); and longer in CAU (16±11); p<0.001.There were no differences in additional ACRc met between ethnic groups. SDI in addition to ESRD was similar in NAI (1.8±2.2) and CAU (2.0±2.5) and lower in ASN (1.2±1.4), p=0.04. Odds of ESRD were increased in NAI (OR 2.6; 95%CI 1.3-5.5) and ASN (OR 3.7; 95%CI 1.6-8.2) compared to CAU. LowInc, LowEduc, and Remote did not increase odds of ESRD. Odds of death were increased in NAI (OR 1.9; 95%CI 1.1-3.2), but not in ASN (OR 0.6; 95%CI 0.2-1.4) compared to CAU. LowInc did not increase odds of death, but LowEduc (OR 3.2; 95%CI 1.8-5.5), and Remote (OR 2.9; 95%CI 1.4-6.0) did. In separate models, after adjustment for age, gender, SDI, ACRc, and age at diagnosis, risk of ESRD was increased in NAI (HR 2.8; 95%CI 1.0-8.1) and ASN (HR 4.0; 95%CI 1.6-10.3) compared to CAU. LowInc, LowEduc, and Remote did not increase risk of ESRD. Only LowEduc (HR 2.1; 95%CI 1.1-3.9) increased the adjusted risk of death; ethnicity, LowInc and Remote were not significant.

Conclusion:

Compared to CAU, NAI and ASN not only have a higher risk of nephritis, but among those with nephritis, risk of ESRD is 3-4 fold higher in NAI and ASN. Lack of education, rather than ethnicity, was the major risk factor for death. Reasons for these differences may include renal pathology, care pathways, comorbid conditions and additional socioeconomic factors and need to be further explored.


Disclosure: C. Peschken, None; R. Gole, None; C. A. Hitchon, None; D. Robinson, None; A. Man, None; A. Tisseverasinghe, None; H. El-Gabalawy, None.

To cite this abstract in AMA style:

Peschken C, Gole R, Hitchon CA, Robinson D, Man A, Tisseverasinghe A, El-Gabalawy H. Outcomes of Lupus Nephritis in Vulnerable Populations [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/outcomes-of-lupus-nephritis-in-vulnerable-populations/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/outcomes-of-lupus-nephritis-in-vulnerable-populations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology